Dr. Bryan Parker Rowe, MD

  • Dover, NH
  • Radiation oncologist
NPI1023279395PAC ID3375790405
Medicare services, 2024
3,205
Medicare patients, 2024
485
Part D claims, 2024
85
Publications
2
Clinical trials
1
Practice address
789 Central Ave, Dover, NH 03820
Practice phone
Call (603) 740-2580
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Wentworth-Douglass Hospital

Hospital · Dover, New Hampshire

See all 8 affiliations

Find Dr. Rowe's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Bryan Parker Rowe is a radiation oncologist in Dover, New Hampshire

Dr. Rowe practices at Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham.

Dr. Rowe's NPI, 1023279395, was assigned on June 19, 2008. Dr. Rowe graduated from University of Connecticut School of Medicine in 2007. Dr. Rowe holds New Hampshire license 15594.

NPI and contact details
Medicare PAC ID
3375790405
NPI enumeration date
June 19, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(603) 740-2580
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Bryan Parker Rowe practices at Wentworth-Douglass Hospital in Dover, New Hampshire

Dr. Rowe's primary practice is Wentworth-Douglass Hospital, at 789 Central Ave, Dover, NH 03820 in Strafford County. The practice phone is (603) 740-2580.

Source: Dmand AI Affiliation Data

Dr. Bryan Parker Rowe is affiliated with 7 sites of care and 1 medical group

Dr. Rowe's primary practice is Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham. Dr. Rowe is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Radiation Oncology Associates, PA. Dmand AI also links Dr. Rowe to 4 more hospitals and 1 therapy and rehab clinic, each named with a free account.

See all 8 affiliations for Dr. Rowe

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Bryan Parker Rowe's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rowe practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Wentworth-Douglass HospitalAvailable with a free account
+6 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Rowe practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Bryan Parker Rowe is one of 28 radiation oncologists in New Hampshire

Radiation oncology is Dr. Rowe's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Rowe's licenses on file in 2 states: New Hampshire and Connecticut.

Specialties and state licenses

  • Radiation oncology, New HampshirePrimaryLicense 15594 · taxonomy 2085R0001X
  • Therapeutic radiology, ConnecticutLicense 00000000000 · taxonomy 2085R0203X

Radiation oncologists near Dr. Rowe

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Bryan Parker Rowe billed Medicare for 3,205 services in 2024

CMS data shows 3,205 Medicare services from Dr. Rowe across 20 procedure codes in 2024, for 485 Medicare patients. Medicare paid $189,154 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20243,205
Medicare patients485
Paid by Medicare$189,154
Procedure codes20

Dr. Rowe's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 2,5382024: 2,82111%
Office and hospital visits
2023: 2772024: 2577%
Other services
2023: 1242024: 1272%

Dr. Rowe compared with the New Hampshire median for radiation oncologists, 2024

  • Dr. Rowe
  • New Hampshire median
Medicare services
3,205vs 2,30339% above
Medicare patients
485vs 2242.2 times
Part D claims
26vs 287% below

Medians across 27 radiation oncologists in New Hampshire with Dmand AI profiles that report each measure.

Dr. Rowe's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Rowe

Need commercial claims for Dr. Rowe?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rowe and other radiation oncologists in New Hampshire.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Bryan Parker Rowe treated 485 Medicare patients in 2024, average age 74

CMS counts 485 Medicare patients who saw Dr. Rowe in 2024. The largest group is 65 to 74, with 226 patients. 75% of them have cancer, and 71% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rowe's median patient age at 70, with 43% women.

Medicare patients, 2024485
Average age74
Average risk score1.47
Also on Medicaid7%

Dr. Rowe's Medicare patients by age, 2024

Dr. Rowe's Medicare patients by sex, 2024

  • Women19640%
  • Men28960%

Chronic conditions among Dr. Rowe's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol71%
  3. High blood pressure68%
  4. Arthritis36%
  5. Anxiety25%
  6. COPD25%
  7. Mood disorders25%
  8. Ischemic heart disease24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Rowe's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women43%
  • Men56%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Bryan Parker Rowe wrote 85 Medicare Part D claims in 2024

In 2024, Dr. Rowe wrote 85 Medicare Part D claims for 48 patients. 85% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $660 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

Part D claims, 202485
Drugs named by CMS2
Total drug cost$660
Part D patients48

Dr. Rowe's Part D claims by kind of drug, 2024

  • Generic72 claims85%
  • Brand-name and other13 claims15%

Dr. Rowe's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Rowe's Part D claims, 2024

  • Opioids15%13 of 85 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 212024: 2624%

Drugs named by CMS: 2 in 2024, 1 in 2023.

See all prescribing by Dr. Rowe

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Bryan Parker Rowe scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rowe for performance year 2024, reported individually. Dr. Rowe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Rowe's MIPS scores, performance year 2024

  • 75of 100Final score
  • 93.3of 100Quality
  • 0of 100Improvement Activities
  • 80of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Rowe by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Bryan Parker Rowe has 2 publications on record

Dmand AI links 2 papers to Dr. Rowe in 2014. Dr. Rowe's most frequent co-authors are Rachel C. Blitzblau, MD, PhD and Frank Christopher Detterbeck, MD.

Papers2

Dr. Rowe's most frequent co-authors

Recent publications by Dr. Rowe

See all 2 publications and co-authors

See who Dr. Rowe researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rowe works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Bryan Parker Rowe has worked on 1 clinical trial

Dmand AI links Dr. Rowe to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

Conditions in Dr. Rowe's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic

Investigators on the most trials with Dr. Rowe

Recent clinical trials with Dr. Rowe

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Bryan Parker Rowe received $164 in industry payments from 2016 to 2021

CMS Open Payments shows 3 general payments to Dr. Rowe from 2 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $146.

General payments to Dr. Rowe by program year, 2016 to 2021

Companies that paid Dr. Rowe the most, 2016 to 2021

Share is of all general payments to this clinician.

See all payments to Dr. Rowe

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Bryan Parker Rowe graduated from University of Connecticut School of Medicine

Dr. Rowe graduated from University of Connecticut School of Medicine in 2007.

  1. Medical schoolUniversity of Connecticut School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Bryan Parker Rowe's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Bryan Parker Rowe

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Bryan Parker Rowe's NPI number?

Dr. Bryan Parker Rowe's NPI number is 1023279395. It was assigned on June 19, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Bryan Parker Rowe?

Dr. Bryan Parker Rowe is a radiation oncologist in Dover, New Hampshire. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Bryan Parker Rowe practice?

Dr. Rowe practices at 789 Central Ave, Dover, NH 03820. Dr. Rowe's primary practice is Wentworth-Douglass Hospital in Dover, New Hampshire, part of Mass General Brigham. Dmand AI also links Dr. Rowe to 4 hospitals and 1 therapy and rehab clinic.

What is Dr. Bryan Parker Rowe's office phone number?

The practice phone on file for Dr. Rowe is (603) 740-2580.

What is Dr. Bryan Parker Rowe's medical license number?

Dr. Rowe holds New Hampshire license 15594, one of the licenses on file in 2 states.

Which states has Dr. Bryan Parker Rowe been licensed in?

Dmand AI has state licenses on file for Dr. Rowe in New Hampshire and Connecticut.

Which hospitals is Dr. Bryan Parker Rowe affiliated with?

Dr. Rowe practices at Wentworth-Douglass Hospital in Dover, New Hampshire. Dr. Rowe is also affiliated with Dartmouth Hitchcock Medical Center. Dmand AI links Dr. Rowe to 4 more hospitals.

What medical group is Dr. Bryan Parker Rowe part of?

Dr. Rowe is linked to Radiation Oncology Associates, PA.

Does Dr. Bryan Parker Rowe accept Medicare?

Yes. CMS data shows Dr. Rowe billed Medicare for 3,205 services in 2024, and Dr. Rowe accepts Medicare assignment.

What is Dr. Bryan Parker Rowe's MIPS score?

Dr. Rowe's MIPS final score for performance year 2024 is 75 out of 100, reported individually.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Bryan Parker Rowe see?

CMS counts 485 Medicare patients who saw Dr. Rowe in 2024, with an average age of 74.

What services does Dr. Bryan Parker Rowe bill to Medicare?

In 2024, Dr. Rowe's most billed Medicare services were radiation oncology (77014), radiation oncology (77334) and radiation oncology (77300).

Where did Dr. Bryan Parker Rowe go to medical school?

Dr. Rowe graduated from University of Connecticut School of Medicine in 2007.

What drugs does Dr. Bryan Parker Rowe prescribe most?

In 2024 Medicare Part D data, Dr. Rowe's most prescribed drugs by claims were Dexamethasone and Oxycodone HCl.

Has Dr. Bryan Parker Rowe received payments from drug or device companies?

CMS Open Payments shows $164 in general payments to Dr. Rowe from 2 companies from 2016 to 2021. The largest total came from Novocure Inc.

How long has Dr. Bryan Parker Rowe been practicing?

Dr. Rowe graduated from medical school in 2007, 19 years ago.

Does Dr. Bryan Parker Rowe do research?

Dmand AI links 2 publications to Dr. Rowe. Dr. Rowe has worked on 1 clinical trial.

Who does Dr. Bryan Parker Rowe publish with?

Dr. Rowe's most frequent co-authors are Rachel C. Blitzblau, MD, PhD (1 shared paper) and Frank Christopher Detterbeck, MD (1 shared paper).

Selling to radiation oncology practices?

See radiation oncologists in New Hampshire by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)